Psychosomatic aspects of movement disorders.
Cummings
J L
JL
D001480:Basal Ganglia Diseases / Q000150:complications / Q000523:psychology; D002114:Calcinosis / Q000150:complications; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D006527:Hepatolenticular Degeneration / Q000150:complications; D006801:Humans; D006816:Huntington Disease / Q000150:complications; D001523:Mental Disorders / Q000150:complications*; D019964:Mood Disorders / Q000150:complications; D009069:Movement Disorders / Q000150:complications / Q000523:psychology*; D009474:Neurons / Q000473:pathology; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications / Q000473:pathology; D010301:Parkinson Disease, Postencephalitic / Q000150:complications; D011602:Psychophysiologic Disorders / Q000523:psychology; D011954:Receptors, Dopamine / Q000502:physiology; D012559:Schizophrenia / Q000150:complications; D005879:Tourette Syndrome / Q000150:complications
D011954:Receptors, Dopamine